-
Something wrong with this record ?
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
U. Zeymer, P. Ludman, N. Danchin, P. Kala, C. Laroche, M. Sadeghi, R. Caporale, SM. Shaheen, J. Legutko, Z. Iakobsishvili, KF. Alhabib, Z. Motovska, M. Studencan, J. Mimoso, D. Becker, D. Alexopoulos, Z. Kereseselidze, S. Stojkovic, P. Zelveian,...
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
- MeSH
- ST Elevation Myocardial Infarction * therapy MeSH
- Cardiology * MeSH
- Percutaneous Coronary Intervention * MeSH
- Humans MeSH
- Hospitals MeSH
- Prospective Studies MeSH
- Registries MeSH
- Myocardial Reperfusion MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe MeSH
AIMS: The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS: Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion. CONCLUSIONS: The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.
Aalborg University Hospital Department of Cardiology Hobrovej 18 22 9100 Aalborg Denmark
Ain shams University Ramsis Street Abbassia Square Cairo Egypt
Centro Hospitalar e Universitário do Algarve R Leao Penedo 8000 386 Faro Portugal
Hôpital Européen Georges Pompidou Service de Cardiologie 20 Rue Leblanc 75015 Paris France
Hospital Rudolfstiftung Juchgasse 25 1030 Wien Austria
Interventional Cardiology Unit Annunziata Civil Hospital Via Migliori 1 87100 Cosenza Italy
Iraqi Scientific Council of Cardiology Baghdad Heart Center Medical City Baghdad Iraq
Jagiellonian University Medical College
Kyrgyz State Medical Academy 92 Akhunbayev St Bishkek Kyrgyzstan
Maria Cecilia Hospital GVM Care and Research Via Corriera 1 48033 Cotignola RA Italy
Mater Dei Hospital Triq Dun Karm L Imsida MSD2090 Msida Malta
National Center of Cardiology and Internal Medicine Togolok Moldo Str 720040 Bishkek Kyrgyzstan
North Estonia Medical Centre J Sütiste tee 19 13419 Tallinn Estonia
Rabin Medical Center Zeev Jabotinsky St 39 Petah Tikva 49100 Israel
Satakunta Cental Hospital Sairaalantie 3 28500 Pori Finland
Spitalul Clinic de Urgenta Floreasca Calea Floreasca 8 București 014461 Romania
St Vincent's University Hospital Merrion Rd Dublin 4 D04 N2E0 Ireland
Teaching Hospital of J A Reiman Cardiocentre Prešov Jána Hollého 5898 14 081 81 Prešov Slovakia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003180
- 003
- CZ-PrNML
- 005
- 20220127150610.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurheartj/ehab342 $2 doi
- 035 __
- $a (PubMed)34389857
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Zeymer, Uwe $u Klinikum der Stadt Ludwigshafen and Institut für Herzinfarktforschung, Bremserstraße 79, 67063 Ludwigshafen am Rhein, Germany
- 245 10
- $a Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology / $c U. Zeymer, P. Ludman, N. Danchin, P. Kala, C. Laroche, M. Sadeghi, R. Caporale, SM. Shaheen, J. Legutko, Z. Iakobsishvili, KF. Alhabib, Z. Motovska, M. Studencan, J. Mimoso, D. Becker, D. Alexopoulos, Z. Kereseselidze, S. Stojkovic, P. Zelveian, A. Goda, E. Mirrakhimov, G. Bajraktari, H. Al-Farhan, P. Šerpytis, B. Raungaard, T. Marandi, AM. Moore, M. Quinn, PP. Karjalainen, G. Tatu-Chitolu, CP. Gale, AP. Maggioni, F. Weidinger, ACVC EAPCI EORP ACS STEMI investigators group of the ESC
- 520 9_
- $a AIMS: The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS: Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5-5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8-97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1-70.1%) for timely reperfusion. CONCLUSIONS: The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.
- 650 12
- $a kardiologie $7 D002309
- 650 _2
- $a nemocnice $7 D006761
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a reperfuze myokardu $7 D015425
- 650 12
- $a koronární angioplastika $7 D062645
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a registrace $7 D012042
- 650 12
- $a infarkt myokardu s elevacemi ST úseků $x terapie $7 D000072657
- 650 _2
- $a výsledek terapie $7 D016896
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ludman, Peter $u Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston 1, Birmingham, B15 2TT, United Kingdom
- 700 1_
- $a Danchin, Nicolas $u Hôpital Européen Georges Pompidou, Service de Cardiologie, 20 Rue Leblanc, 75015 Paris, France
- 700 1_
- $a Kala, Petr $u University Hospital Brno, Medical Faculty of Masaryk University, Dept of Internal Medicine and Cardiology, Kamenice 5, 625 00 Bohunice, Brno, Czech Republic
- 700 1_
- $a Laroche, Cécile $u EURObservational Research Programme, European Society of Cardiology, European Heart House, 2035 Route des Colles, Sophia Antipolis, France
- 700 1_
- $a Sadeghi, Masoumeh $u Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Shahid Rahmani Alley, Moshtagh Sevom Street, Isfahan, Iran
- 700 1_
- $a Caporale, Roberto $u Interventional Cardiology Unit, Annunziata Civil Hospital, Via Migliori 1, 87100 Cosenza, Italy
- 700 1_
- $a Shaheen, Sameh Mohamed $u Ain shams University, Ramsis Street, Abbassia Square, Cairo, Egypt
- 700 1_
- $a Legutko, Jacek $u Jagiellonian University Medical College; Institute of Cardiology, Department of Interventional Cardiology, John Paul II Hospital, Prądnicka 80, 31-202 Kraków, Poland
- 700 1_
- $a Iakobsishvili, Zaza $u Rabin Medical Center, Zeev Jabotinsky St 39, Petah Tikva, 49100 Israel
- 700 1_
- $a Alhabib, Khalid F $u Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia
- 700 1_
- $a Motovska, Zuzana $u Cardiocenter, Third Faculty of Medicine Charles Univ. and Univ. Hospital Kralovske Ruská 2411, 100 00 Praha 10-Vinohrady, Czech Republic
- 700 1_
- $a Studencan, Martin $u Teaching Hospital of J.A. Reiman, Cardiocentre Prešov, Jána Hollého 5898/14, 081 81 Prešov, Slovakia
- 700 1_
- $a Mimoso, Jorge $u Centro Hospitalar e Universitário do Algarve, R. Leao Penedo, 8000-386 Faro, Portugal
- 700 1_
- $a Becker, David $u Deputy-Director of the Heart and Vascular Center of Semmelweis University, Gaál József út 9, 1122 Budapest, Hungary
- 700 1_
- $a Alexopoulos, Dimitrios $u National and Kapodistrian University of Athens, Attikon University Hospital, Rimini 1, Chaidari 124 62, Greece
- 700 1_
- $a Kereseselidze, Zviad $u Chapidze Emergency Cardiology Center, 0159, Didube-Chugureti District, Nino Javakhishvili str., Tbilisi, Georgia
- 700 1_
- $a Stojkovic, Sinisa $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Department of Cardiology, Clinical Center of Serbia, Pasterova 2, Beograd 11000 Belgrade, Serbia
- 700 1_
- $a Zelveian, Parounak $u Scientific Research Institute of Cardiology named after Levon Hovhannisyan, 0014, Yerevan, Paruyr Sevaki St., 5 Building (Kanaker-Zeytun adm. district), Yerevan, Armenia
- 700 1_
- $a Goda, Artan $u Cardiology I & Cardiology II, University Hospital Center Mother Theresa, Rruga e Dibrës 372 Tirana AL, 1000, Albania
- 700 1_
- $a Mirrakhimov, Erkin $u Kyrgyz State Medical Academy, 92 Akhunbayev St, Bishkek, Kyrgyzstan $u National Center of Cardiology and Internal Medicine, Togolok Moldo Str., 720040, Bishkek, Kyrgyzstan
- 700 1_
- $a Bajraktari, Gani $u Medical Faculty, University of Prishtina "Hasan Prishtina", University Clinical Centre of Kosova, Pristina 10000, Kosovo
- 700 1_
- $a Al-Farhan, Hasan $u Iraqi Scientific Council of Cardiology, Baghdad Heart Center, Medical City, Baghdad, Iraq
- 700 1_
- $a Šerpytis, Pranas $u Vilnius University Faculty of Medicine Hospital Santaros Klinikos, 08406, Santariškių g. 2, Vilnius 08410, Lithuania
- 700 1_
- $a Raungaard, Bent $u Aalborg University Hospital, Department of Cardiology, Hobrovej 18-22, 9100 Aalborg, Denmark
- 700 1_
- $a Marandi, Toomas $u North Estonia Medical Centre, J. Sütiste tee 19, 13419 Tallinn, Estonia
- 700 1_
- $a Moore, Alice May $u Mater Dei Hospital, Triq Dun Karm, L-Imsida, MSD2090 Msida, Malta
- 700 1_
- $a Quinn, Martin $u St Vincent's University Hospital, Merrion Rd, Dublin 4, D04 N2E0, Ireland
- 700 1_
- $a Karjalainen, Pasi Paavo $u Satakunta Cental Hospital, Sairaalantie 3, 28500 Pori, Finland
- 700 1_
- $a Tatu-Chitolu, Gabriel $u Spitalul Clinic de Urgenta "Floreasca", Calea Floreasca 8, București 014461, Romania
- 700 1_
- $a Gale, Chris P $u Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds School of Medicine, Worsley Building, University of Leeds, LS2 9JT Leeds, UK
- 700 1_
- $a Maggioni, Aldo P $u EURObservational Research Programme, European Society of Cardiology, European Heart House, 2035 Route des Colles, Sophia Antipolis, France $u Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1, 48033 Cotignola RA, Italy
- 700 1_
- $a Weidinger, Franz $u Hospital Rudolfstiftung, Juchgasse 25, 1030 Wien, Austria
- 710 2_
- $a ACVC EAPCI EORP ACS STEMI investigators group of the ESC
- 773 0_
- $w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 42, č. 44 (2021), s. 4536-4549
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34389857 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150606 $b ABA008
- 999 __
- $a ok $b bmc $g 1750828 $s 1154329
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 42 $c 44 $d 4536-4549 $e 20211121 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
- LZP __
- $a Pubmed-20220113
